BBIO vs KRYS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

BBIO

32.9
AI Score
VS
KRYS Wins

KRYS

52.0
AI Score

Investment Advisor Scores

BBIO

33score
Recommendation
EXTENDED

KRYS

52score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric BBIO KRYS Winner
Forward P/E 0 39.5257 Tie
PEG Ratio 0 0 Tie
Revenue Growth 192.6% 30.2% BBIO
Earnings Growth 0.0% -22.9% BBIO
Tradestie Score 32.9/100 52.0/100 KRYS
Profit Margin -59.8% 47.9% KRYS
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED BUY KRYS

Relative Price Performance (Last 90 Days)

BBIO 1M: +20.4% · 3M: -2.1% KRYS 1M: -7.6% · 3M: -8.0%

Current Technical Phase

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $78.17

KRYS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 43

RSI (14): 43.4 · Price: $305.68

Fundamentals Snapshot

Metric BBIO KRYS
Market Cap — —
Forward P/E -286.0 33.1
Trailing P/E — 42.0
Revenue (TTM) — —
Revenue Growth 1.9% 0.3%
Gross Margin 0.9% 0.9%
Operating Margin -0.4% 0.5%
EPS -3.07 7.36
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, KRYS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.